Cereton

Capsules 400 mg

Composition: 1 capsule contains: Active ingredient: choline alfoscerate, calculated as 100% substance — 400 mg. Excipients: glycerol, purified water — to obtain a fill weight of 590 mg. Capsule shell: gelatin, sorbitol, glycerol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, titanium dioxide, yellow iron oxide, purified water.

Form: Capsules.

Indications: • Recovery periods of severe traumatic brain injury and ischaemic stroke, and the recovery period of haemorrhagic stroke, accompanied by focal hemispheric symptoms or symptoms of brainstem damage. • Psychoorganic syndrome associated with degenerative and involutional changes in the brain. • Cognitive disorders (impaired thinking and memory, confusion, disorientation, reduced motivation, initiative and ability to concentrate), including those associated with dementia and encephalopathy. • Senile pseudomelancholia.

Contraindications: • Hypersensitivity to the medicine. • Acute stage of haemorrhagic stroke. • Pregnancy. • Breastfeeding. • Children and adolescents under 18 years of age (due to lack of data).

Dosage: During recovery from traumatic brain injury, ischaemic or haemorrhagic stroke, Cereton® is prescribed at 800 mg in the morning and 400 mg in the daytime for 6 months. For chronic cerebrovascular insufficiency and dementia syndromes, Cereton® is prescribed at 400 mg (1 capsule) 3 times daily, preferably after meals, for 3–6 months.

Side effects: Nausea may occur, mainly as a consequence of dopaminergic activation. Discontinuation is not required; a temporary dose reduction is sufficient. Allergic reactions.

Interactions: No significant interactions with other medicines have been identified.

Warnings: Cereton® does not affect the speed of psychomotor reactions. Keep out of reach of children and do not use after the expiry date.

Age restrictions: From 18 years old

Pregnancy: Contraindicated during pregnancy and breastfeeding

Country of origin: Russia

Manufacturer: Artlife LLC, 8/2 Nakhimova Street, Tomsk, 634034 — PharmFirma Sotex CJSC, 11 Belikovo settlement, Bereznyakovskoye rural settlement, Sergiyev Posad municipal district, Moscow region, Russia, 141345. Tel./fax: (495) 956-29-30. Marketing authorisation holder / consumer complaints address: PharmFirma Sotex CJSC, at the same Belikovo address. Tel./fax: (495) 956-29-30.

Storage conditions: Store in a dry place protected from light at a temperature not exceeding 25°C.

Shelf life: 3 years.

Dispensing conditions: Prescription only.